<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Results for Bajetta, Emilio</title>
    <description>Showing 1 - 14 results of 14</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;author=%22Bajetta%2C+Emilio%22&amp;type=Author</link>
    <opensearch:totalResults>14</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="%22Bajetta%2C%20Emilio%22" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Bajetta%2C+Emilio%22&amp;type=Author"/>
    <atom:link rel="last" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Bajetta%2C+Emilio%22&amp;type=Author"/>
    <atom:link rel="self" type="application/rss+xml" href="https://buscaintegrada.ufrj.br/Author/?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;author=%22Bajetta%2C+Emilio%22&amp;type=Author"/>
    <item>
      <title>The cost of unresectable stage III or stage IV melanoma in Italy</title>
      <pubDate>Sun, 01 Jan 2012 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/oai:doaj.org-article:5e439b7265ab49dc9334e6bbb6a3e6cc</link>
      <guid>https://buscaintegrada.ufrj.br/Record/oai:doaj.org-article:5e439b7265ab49dc9334e6bbb6a3e6cc</guid>
      <author>Maio Michele</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012-11-01</dc:date>
      <dc:creator>Maio Michele</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report</title>
      <pubDate>Fri, 01 Jan 2010 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-2920000</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-2920000</guid>
      <author>Valente, Monica</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2010</dc:date>
      <dc:creator>Valente, Monica</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Pitfalls in neuroendocrine tumor diagnosis</title>
      <pubDate>Thu, 01 Jan 2009 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-2994471</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-2994471</guid>
      <author>Bajetta, Emilio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2009</dc:date>
      <dc:creator>Bajetta, Emilio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron</title>
      <pubDate>Thu, 01 Jan 2009 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3004669</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3004669</guid>
      <author>Bajetta, Emilio</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2009</dc:date>
      <dc:creator>Bajetta, Emilio</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial</title>
      <pubDate>Fri, 01 Jan 2010 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3128271</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3128271</guid>
      <author>Celio, Luigi</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2010</dc:date>
      <dc:creator>Celio, Luigi</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of individual patient data examining the effect of age on outcome in two phase III trials</title>
      <pubDate>Sun, 01 Jan 2012 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3538015</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3538015</guid>
      <author>Celio, Luigi</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012</dc:date>
      <dc:creator>Celio, Luigi</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>The cost of unresectable stage III or stage IV melanoma in Italy</title>
      <pubDate>Sun, 01 Jan 2012 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3542007</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3542007</guid>
      <author>Maio, Michele</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2012</dc:date>
      <dc:creator>Maio, Michele</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study</title>
      <pubDate>Tue, 01 Jan 2013 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3556255</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3556255</guid>
      <author>Castellano, Daniel</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Castellano, Daniel</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens</title>
      <pubDate>Tue, 01 Jan 2013 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-3725595</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-3725595</guid>
      <author>Ng, Kimmie</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Ng, Kimmie</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme</title>
      <pubDate>Tue, 01 Jan 2013 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4029467</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4029467</guid>
      <author>Altomonte, Maresa</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2013</dc:date>
      <dc:creator>Altomonte, Maresa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens</title>
      <pubDate>Wed, 01 Jan 2014 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4190566</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4190566</guid>
      <author>Martinetti, Antonia</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Martinetti, Antonia</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis</title>
      <pubDate>Thu, 01 Jan 2015 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-4609826</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-4609826</guid>
      <author>Strosberg, Jonathan R</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2015</dc:date>
      <dc:creator>Strosberg, Jonathan R</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors</title>
      <pubDate>Mon, 01 Jan 2018 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-5920017</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-5920017</guid>
      <author>Pusceddu, Sara</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2018</dc:date>
      <dc:creator>Pusceddu, Sara</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement</title>
      <pubDate>Mon, 01 Jan 2018 01:39:35 -0200</pubDate>
      <link>https://buscaintegrada.ufrj.br/Record/pubmed-6193744</link>
      <guid>https://buscaintegrada.ufrj.br/Record/pubmed-6193744</guid>
      <author>Dottorini, Lorenzo</author>
      <dc:format>Artigo</dc:format>
      <dc:date>2018</dc:date>
      <dc:creator>Dottorini, Lorenzo</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
